S&CO Inc’s Eli Lilly LLY Stock Holding History

S&CO Inc’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8M	Buy	21,519 +1,310	+6%	+$1.33M	1.23%	23
2025 Q4	$21.7M	Buy	20,209 +181	+0.9%	+$173K	1.35%	21
2025 Q3	$15.3M	Buy	20,028 +7,928	+66%	+$5.9M	0.94%	30
2025 Q2	$9.43M	Buy	12,100 +440	+4%	+$342K	0.6%	43
2025 Q1	$9.63M	Buy	11,660 +5,550	+91%	+$4.62M	0.65%	41
2024 Q4	$4.72M	Hold	6,110	–	–	0.32%	70
2024 Q3	$5.41M	Sell	6,110 -40	-0.7%	-$36K	0.35%	63
2024 Q2	$5.57M	Sell	6,150 -525	-8%	-$420K	0.39%	57
2024 Q1	$5.19M	Sell	6,675 -1,150	-15%	-$818K	0.37%	60
2023 Q4	$4.56M	Sell	7,825 -670	-8%	-$391K	0.35%	64
2023 Q3	$4.56M	Hold	8,495	–	–	0.37%	58
2023 Q2	$3.98M	Sell	8,495 -35	-0.4%	-$14.7K	0.32%	62
2023 Q1	$2.93M	Sell	8,530 -115	-1%	-$38.8K	0.25%	71
2022 Q4	$3.16M	Sell	8,645 -15	-0.2%	-$5.32K	0.28%	67
2022 Q3	$2.8M	Sell	8,660 -80	-0.9%	-$25.3K	0.25%	71
2022 Q2	$2.83M	Sell	8,740 -50	-0.6%	-$15K	0.24%	73
2022 Q1	$2.52M	Hold	8,790	–	–	0.18%	88
2021 Q4	$2.43M	Hold	8,790	–	–	0.17%	95
2021 Q3	$2.03M	Sell	8,790 -50	-0.6%	-$12.3K	0.16%	96
2021 Q2	$2.03M	Hold	8,840	–	–	0.16%	100
2021 Q1	$1.65M	Hold	8,840	–	–	0.14%	98
2020 Q4	$1.49M	Hold	8,840	–	–	0.13%	102
2020 Q3	$1.31M	Sell	8,840 -155	-2%	-$24K	0.13%	101
2020 Q2	$1.48M	Hold	8,995	–	–	0.16%	93
2020 Q1	$1.25M	Hold	8,995	–	–	0.17%	86
2019 Q4	$1.18M	Hold	8,995	–	–	0.12%	97
2019 Q3	$1.01M	Hold	8,995	–	–	0.11%	109
2019 Q2	$997K	Hold	8,995	–	–	0.11%	108
2019 Q1	$1.17M	Hold	8,995	–	–	0.13%	99
2018 Q4	$1.04M	Hold	8,995	–	–	0.13%	99
2018 Q3	$965K	Hold	8,995	–	–	0.11%	112
2018 Q2	$768K	Hold	8,995	–	–	0.09%	119
2018 Q1	$696K	Hold	8,995	–	–	0.09%	115
2017 Q4	$760K	Hold	8,995	–	–	0.09%	108
2017 Q3	$769K	Buy	8,995 +100	+1%	+$8.2K	0.1%	109
2017 Q2	$732K	Buy	8,895 +1,325	+18%	+$108K	0.1%	109
2017 Q1	$637K	Hold	7,570	–	–	0.09%	109
2016 Q4	$557K	Hold	7,570	–	–	0.08%	113
2016 Q3	$608K	Hold	7,570	–	–	0.09%	113
2016 Q2	$596K	Buy	7,570 +900	+13%	+$67.8K	0.09%	110
2016 Q1	$480K	Hold	6,670	–	–	0.08%	108
2015 Q4	$562K	Hold	6,670	–	–	0.09%	107
2015 Q3	$558K	Hold	6,670	–	–	0.1%	108
2015 Q2	$557K	Hold	6,670	–	–	0.08%	108
2015 Q1	$485K	Hold	6,670	–	–	0.07%	110
2014 Q4	$460K	Hold	6,670	–	–	0.07%	110
2014 Q3	$433K	Buy	+6,670	New	+$422K	0.07%	107

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

S&CO Inc's LLY Position: Q1 2026 in Review

S&CO Inc increased its Eli Lilly (LLY) stake by 6.5% in Q1 2026, buying an estimated $1.33M and bringing the position to 21,519 shares worth $19.8M. The position accounts for 1.23% of the portfolio, ranked #23.

S&CO Inc first reported a position in LLY in Q3 2014 and has held it in 47 quarters since. The position peaked at $21.7M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

S&CO Inc held 21,519 shares of Eli Lilly worth $19.8M as of Q1 2026.
S&CO Inc bought 1,310 Eli Lilly shares in Q1 2026, an estimated $1.33M.
Eli Lilly made up 1.23% of S&CO Inc's portfolio in Q1 2026, its #23 holding.
S&CO Inc first reported a position in Eli Lilly in Q3 2014 and has held it in 47 quarters since.
S&CO Inc's Eli Lilly position peaked at $21.7M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.